drug: atomoxetine |
|
|
| Clinical class | anti-ADHD, antidepressant |
| Action | presynaptic norepinephrine transporter antagonist |
| Chemical class | benzenepropanamine derivative |
| CSA schedule | none |
| DEA number | none |
| Routes of administration | oral, parenteral (including depot) |
| Associated with (substance-related)
|
disorders: none |
| Availability | prescription |
Also: tomoxetine
U.S. Preparations:
- Strattera™ (Lilly) FDA
approved for:
11.26.2002 treatment of Attention Deficit Hyperactivity Disorder
5.7.2008 maintenance treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents
US Prescribing Information